Development and Validation of a Diabetic Retinopathy Risk Stratification Algorithm
Diabetes Care · 2023
DOI: 10.2337/dc22-1168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Care, 2023. Verfasst von Dariusz Tarasewicz und 7 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Ophthalmology, The Permanente Medical Group, Oakland, CA. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Macular Edema, Diabetes Mellitus. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIA NIH HHS, NIDDK Centers for Diabetes Translational Research.
Abstract (Originalsprache)
OBJECTIVE Although diabetic retinopathy is a leading cause of blindness worldwide, diabetes-related blindness can be prevented through effective screening, detection, and treatment of disease. The study goal was to develop risk stratification algorithms for the onset of retinal complications of diabetes, including proliferative diabetic retinopathy, referable retinopathy, and macular edema. RESEARCH DESIGN AND METHODS Retrospective cohort analysis of patients from the Kaiser Permanente Northern California Diabetes Registry who had no evidence of diabetic retinopathy at a baseline diabetic retinopathy screening during 2008–2020 was performed. Machine learning and logistic regression prediction models for onset of proliferative diabetic retinopathy, diabetic macular edema, and referable retinopathy detected through routine screening were trained and internally validated. Model performance was assessed using area under the curve (AUC) metrics. RESULTS The study cohort (N = 276,794) was 51.9% male and 42.1% White. Mean (±SD) age at baseline was 60.0 (±13.1) years. A machine learning XGBoost algorithm was effective in identifying patients who developed proliferative diabetic retinopathy (AUC 0.86; 95% CI, 0.86–0.87), diabetic macular edema (AUC 0.76; 95% CI, 0.75–0.77), and referable retinopathy (AUC 0.78; 95% CI, 0.78–0.79). Similar results were found using a simpler nine-covariate logistic regression model: proliferative diabetic retinopathy (AUC 0.82; 95% CI, 0.80–0.83), diabetic macular edema (AUC 0.73; 95% CI, 0.72–0.74), and referable retinopathy (AUC 0.75; 95% CI, 0.75–0.76). CONCLUSIONS Relatively simple logistic regression models using nine readily available clinical variables can be used to rank order patients for onset of diabetic eye disease and thereby more efficiently prioritize and target screening for at risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 1Department of Ophthalmology, The Permanente Medical Group, Oakland, CA.
- 2Division of Research, Kaiser Permanente, Oakland, CA.
ORCID-Profile: Dariusz Tarasewicz, Andrew J Karter, Ronald B Melles
Förderung
- NIDDK NIH HHS
- NIA NIH HHS
- NIDDK Centers for Diabetes Translational Research
- The Permanente Medical Group Delivery Science Grants Program
Zitieren
APA
Tarasewicz, D., Karter, A. J., Pimentel, N., Moffet, H. H., Thai, K. K., Schlessinger, D., Sofrygin, O., & Melles, R. B. (2023). Development and Validation of a Diabetic Retinopathy Risk Stratification Algorithm. Diabetes Care. https://doi.org/10.2337/dc22-1168
Vancouver
Tarasewicz D, Karter AJ, Pimentel N, Moffet HH, Thai KK, Schlessinger D, et al. Development and Validation of a Diabetic Retinopathy Risk Stratification Algorithm. Diabetes Care. 2023. doi:10.2337/dc22-1168
BibTeX
@article{Tarasewicz2023,
author = {Tarasewicz, Dariusz and Karter, Andrew J and Pimentel, Noel and Moffet, Howard H and Thai, Khanh K and Schlessinger, David and Sofrygin, Oleg and Melles, Ronald B},
title = {Development and Validation of a Diabetic Retinopathy Risk Stratification Algorithm},
journal = {Diabetes Care},
year = {2023},
doi = {10.2337/dc22-1168}
}
EUVIMED